Showing 9721-9730 of 18563 results for "".
- AI-Powered Imaging Revolutionizes Early Glaucoma Detectionhttps://reachmd.com/news/ai-powered-imaging-revolutionizes-early-glaucoma-detection/2475149/AI-Powered Imaging is revolutionizing ophthalmology by enabling detection of glaucomatous changes at a stage before clinical methods can reveal functional loss, opening a new window to prevent irreversible vision damage. Early glaucoma
- Evolving Cancer and Cardiovascular Safety in JAK Inhibitorshttps://reachmd.com/news/evolving-cancer-and-cardiovascular-safety-in-jak-inhibitors/2475152/As JAK inhibitors become integral to rheumatoid arthritis management, emerging safety data from EULAR 2025 highlight evolving cancer and cardiovascular considerations that will shape patient monitoring and treatment decisions. The
- Optimizing Timing in Intracranial Pressure Monitoring: Advancing Strategies for Neurosurgical and ICU Practiceshttps://reachmd.com/news/optimizing-timing-in-intracranial-pressure-monitoring-advancing-strategies-for-neurosurgical-and-icu-practices/2475159/Significant differences in timing between neurosurgeons and ICU physicians, as reported in the TIMING-ICP study, affect the management of intracranial hypertension.
- Gut-Brain Insights in Parkinson’s: New Avenues for Comprehensive Carehttps://reachmd.com/news/gut-brain-insights-in-parkinsons-new-avenues-for-comprehensive-care/2475169/Recent insights into gut-brain signaling expose how microbial imbalances, potentiated by environmental chemicals, accelerate non-motor symptom burden in Parkinson’s disease. Despite advances in dopaminergic therapies, neurologists rout
- Modern Impacts of Lifestyle and Environmental Factors on Hypertension Riskhttps://reachmd.com/news/modern-impacts-of-lifestyle-and-environmental-factors-on-hypertension-risk/2475161/Modern environmental and lifestyle factors are reshaping our understanding of hypertension risk, revealing that non-genetic influences like per- and polyfluoroalkyl substances and seasonal behaviors can drive blood pressure elevations startin
- Hypertension Management: The Impact of FDA's Two-Front Innovationhttps://reachmd.com/news/hypertension-management-the-impact-of-fdas-two-front-innovation/2475162/Clinicians face stubborn adherence gaps and variable patient responses in hypertension, yet the FDA approval of a three-agent single-tablet combination and emerging genetic insights are poised to transform management strategies. Despit
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/GALDA-Co-Director-Explains-Organizations-Work-Impact/2475171/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- New IL-13/IL-31R Bispecific Antibody Data Presented at EAACIhttps://reachmd.com/news/New-IL-13-IL-31R-Bispecific-Antibody-Data-Presented-EAACI/2475170/A new IL-13/IL-31R bispecific antibody demonstrated ability to simultaneously suppress the inflammatory and pruritogenic pathways in atopic dermatitis (AD), according to preclinical study data presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, S
- Early Intensive Therapy and Immunization in Psoriatic Arthritishttps://reachmd.com/news/early-intensive-therapy-and-immunization-in-psoriatic-arthritis/2475137/Early intensive therapy in psoriatic arthritis (PsA) and robust immunization protocols are redefining care pathways, offering the potential to alter disease trajectories and protect patients from complications of immunosuppression. Rhe